T. Rowe Price Associates’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $74.3M | Sell |
|
|||||
|
2020
Q2 | $212M | Buy |
|
|||||
|
2020
Q1 | $161M | Buy |
|
|||||
|
2019
Q4 | $116M | Buy |
|
|||||
|
2019
Q3 | $68M | Sell |
|
|||||
|
2019
Q2 | $67M | Sell |
|
|||||
|
2019
Q1 | $82.6M | Buy |
|
|||||
|
2018
Q4 | $62.2M | Buy |
|
|||||
|
2018
Q3 | $79.2M | Buy |
|
|||||
|
2018
Q2 | $16.8M | Buy |
|
|||||
|
2018
Q1 | $14.7M | Sell |
|
|||||
|
2017
Q4 | $16.7M | Buy |
|
|||||
|
2017
Q3 | $14.9M | Sell |
|
|||||
|
2017
Q2 | $13.6M | Sell |
|
|||||
|
2017
Q1 | $11.8M | Sell |
|
|||||
|
2016
Q4 | $15.2M | Buy |
|
|||||
|
2016
Q3 | $11.1M | Sell |
|
|||||
|
2016
Q2 | $10.3M | Sell |
|
|||||
|
2016
Q1 | $9.32M | Sell |
|
|||||
|
2015
Q4 | $18.8M | Sell |
|
|||||
|
2015
Q3 | $21.7M | Sell |
|
|||||
|
2015
Q2 | $90.9M | Sell |
|
|||||
|
2015
Q1 | $67.1M | Buy |
|
|||||
|
2014
Q4 | $31.2M | Sell |
|
|||||
|
2014
Q3 | $29.6M | Sell |
|
|||||
|
2014
Q2 | $31.6M | Sell |
|
|||||
|
2014
Q1 | $38.2M | Sell |
|
|||||
|
2013
Q4 | $65.4M | Sell |
|
|||||
|
2013
Q3 | $53.2M | Sell |
|
|||||
|
2013
Q2 | $56.4M | Buy |
|